重大事件
即時報告
8-K
2026-06-22
Unicycive Therapeutics 提交8-K報告股東大會表決結果
AI 繁中摘要
Unicycive Therapeutics（股票代碼：UNCY）於2026年6月22日向SEC提交8-K表格，報告2026年6月19日舉行的股東大會表決結果（Item 5.07）。是次會議股東就多項提案進行投票，包括董事選舉及其他治理事項。公司未有在該8-K中披露具體投票細項數字或管理層評論，亦無觸及業績或財務指引。對投資者而言，此申報僅屬例行合規披露，未提供影響股價的直接新資訊，惟需留意股東表決結果或反映投資者對公司現行策略的支持度。
展開英文正文
EDGAR Filing Documents for 0001213900-26-070316 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001213900-26-070316 Filing Date 2026-06-22 Accepted 2026-06-22 06:05:49 Documents 11 Period of Report 2026-06-19 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 CURRENT REPORT ea0295382-8k_unicycive.htm iXBRL 8-K 35576 Complete submission text file 0001213900-26-070316.txt 202687 Data Files Seq Description Document Type Size 2 XBRL SCHEMA FILE uncy-20260619.xsd EX-101.SCH 3017 3 XBRL LABEL FILE uncy-20260619_lab.xml EX-101.LAB 34239 4 XBRL PRESENTATION FILE uncy-20260619_pre.xml EX-101.PRE 22360 14 EXTRACTED XBRL INSTANCE DOCUMENT ea0295382-8k_unicycive_htm.xml XML 3310 Mailing Address 1975 W. EL CAMINO REAL, SUITE 204 MOUNTAIN VIEW CA 94040 Business Address 1975 W. EL CAMINO REAL, SUITE 204 MOUNTAIN VIEW CA 94040 650-384-0642 Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings) EIN.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40582 | Film No.: 261104780 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)